Literature DB >> 17965611

The Odyssey of MeCP2 and parental imprinting.

Janine M LaSalle1.   

Abstract

DNA methylation in mammals has long been implicated in the epigenetic mechanism of parental imprinting, in which selective expression of one allele of specific genes is based on parental origin. Methyl CpG binding protein 2 (MeCP2) selectively binds to methylated DNA and mutations in the MECP2 cause the autism-spectrum neurodevelopmental disorder Rett syndrome. This review outlines the emerging story of how MeCP2 has been implicated in the regulation of specific imprinted genes and loci, including UBE3A and DLX5. The story of MeCP2 and parental imprinting has unfolded with some interesting but unexpected twists, revealing new insights on the function of MeCP2 in the process.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17965611      PMCID: PMC1866173          DOI: 10.4161/epi.2.1.3697

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  94 in total

1.  The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.

Authors:  Francois Fuks; Paul J Hurd; Daniel Wolf; Xinsheng Nan; Adrian P Bird; Tony Kouzarides
Journal:  J Biol Chem       Date:  2002-11-09       Impact factor: 5.157

2.  Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development.

Authors:  B Hendrich; J Guy; B Ramsahoye; V A Wilson; A Bird
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

3.  DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.

Authors:  Robert J Klose; Shireen A Sarraf; Lars Schmiedeberg; Suzanne M McDermott; Irina Stancheva; Adrian P Bird
Journal:  Mol Cell       Date:  2005-09-02       Impact factor: 17.970

Review 4.  Methyl-CpG-binding protein 2 mutations in Rett syndrome.

Authors:  I B Van den Veyver; H Y Zoghbi
Journal:  Curr Opin Genet Dev       Date:  2000-06       Impact factor: 5.578

5.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

6.  Allele-specific replication timing of imprinted gene regions.

Authors:  D Kitsberg; S Selig; M Brandeis; I Simon; I Keshet; D J Driscoll; R D Nicholls; H Cedar
Journal:  Nature       Date:  1993-07-29       Impact factor: 49.962

7.  Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene.

Authors:  C Y Howell; T H Bestor; F Ding; K E Latham; C Mertineit; J M Trasler; J R Chaillet
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

8.  MECP2 mutation in male patients with non-specific X-linked mental retardation.

Authors:  A Orrico; C Lam; L Galli; M T Dotti; G Hayek; S F Tong; P M Poon; M Zappella; A Federico; V Sorrentino
Journal:  FEBS Lett       Date:  2000-09-22       Impact factor: 4.124

9.  Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.

Authors:  Shin-ichi Horike; Shutao Cai; Masaru Miyano; Jan-Fang Cheng; Terumi Kohwi-Shigematsu
Journal:  Nat Genet       Date:  2004-12-19       Impact factor: 38.330

10.  The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Authors:  Qiang Chang; Gargi Khare; Vardhan Dani; Sacha Nelson; Rudolf Jaenisch
Journal:  Neuron       Date:  2006-02-02       Impact factor: 17.173

View more
  12 in total

Review 1.  Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders.

Authors:  John L R Rubenstein
Journal:  J Child Psychol Psychiatry       Date:  2010-08-24       Impact factor: 8.982

2.  A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations.

Authors:  Alexander H Joyner; Cooper Roddey J; Cinnamon S Bloss; Trygve E Bakken; Lars M Rimol; Ingrid Melle; Ingrid Agartz; Srdjan Djurovic; Eric J Topol; Nicholas J Schork; Ole A Andreassen; Anders M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-26       Impact factor: 11.205

3.  Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.

Authors:  Jill D Jacobson; Kathryn A Ellerbeck; Kelsie A Kelly; Kandace K Fleming; T Rene Jamison; Charles W Coffey; Catherine M Smith; R Matthew Reese; Scott A Sands
Journal:  Psychoneuroendocrinology       Date:  2013-11-26       Impact factor: 4.905

4.  Chromatin modifiers, cognitive disorders, and imprinted genes.

Authors:  Melissa D Cunningham; Judith A Kassis; Karl Pfeifer
Journal:  Dev Cell       Date:  2010-02-16       Impact factor: 12.270

Review 5.  Diet and the epigenetic (re)programming of phenotypic differences in behavior.

Authors:  Patrick O McGowan; Michael J Meaney; Moshe Szyf
Journal:  Brain Res       Date:  2008-07-29       Impact factor: 3.252

Review 6.  MicroRNAs and epigenetic regulation in the mammalian inner ear: implications for deafness.

Authors:  Lilach M Friedman; Karen B Avraham
Journal:  Mamm Genome       Date:  2009-10-30       Impact factor: 2.957

7.  Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism.

Authors:  C S Loat; S Curran; C M Lewis; J Duvall; D Geschwind; P Bolton; I W Craig
Journal:  Genes Brain Behav       Date:  2008-10       Impact factor: 3.449

Review 8.  Noncoding RNAs in mental retardation.

Authors:  K E Szulwach; P Jin; R S Alisch
Journal:  Clin Genet       Date:  2009-01-20       Impact factor: 4.438

9.  Blood mercury concentrations in CHARGE Study children with and without autism.

Authors:  Irva Hertz-Picciotto; Peter G Green; Lora Delwiche; Robin Hansen; Cheryl Walker; Isaac N Pessah
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

10.  A role for MeCP2 in switching gene activity via chromatin unfolding and HP1γ displacement.

Authors:  Maartje C Brink; Diewertje G E Piebes; Marloes L de Groote; Martijn S Luijsterburg; Corella S Casas-Delucchi; Roel van Driel; Marianne G Rots; M Cristina Cardoso; Pernette J Verschure
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.